Home | Welcome to Contract Pharma   
Last Updated Wednesday, May 22 2013
Print

Industry News

Related Searches:

Filter by:

October 28, 2008
Avid Bioservices, Inc. has signed a manufacturing supply agreement with Catalyst Biosciences to produce clinical-grade material for Catalyst's drug candidate, CB 813, a new version of factor VIIa for the treatment of acute bleeding in hemophilia pati…   Read More »
October 27, 2008
Bilcare Global Clinical Supplies has expanded its global distribution and warehousing capabilities for clinical trial supplies. The company has signed a service agreement with World Courier to use depots in Argentina, Brazil, Colombia, Chile, Mexico,…   Read More »
October 27, 2008
Celgene has terminated its licensing agreement with MethylGene for oncology histone deacetylase (HDAC) inhibitors, including MGCD0103. As a result, MethylGene will reacquire the rights to these programs. MethylGene also announced plans to implement a…   Read More »
October 23, 2008
Patheon has opened a new Pharmaceutical Development Services (PDS) suite at its Whitby Development Center in Canada for the small-scale development and manufacturing of solid dosage forms for early clinical studies.     The 2,500-sq…   Read More »
October 22, 2008
Merck plans to eliminate 7,200 jobs by the end of 2011 as part of a new restructuring program aimed at lowering overhead and becoming more competitive. As part of the program, Merck will streamline management layers by eliminating about 25% of senior…   Read More »
October 22, 2008
Amylin Pharmaceuticals and Lilly have entered into a product supply agreement for exenatide once weekly, a compound under development to treat type 2 diabetes. Under terms of the agreement, Amylin will receive an initial cash payment of $125 million…   Read More »
October 21, 2008
Azopharma Product Development Group has entered the microdosing market and will provide services to synthesize material open to microdose studies as well as formulate and administer microdoses in a clinical setting, and analyze samples.   …   Read More »
October 21, 2008
Laureate Pharma has entered into a cGMP contract manufacturing agreement with Tolerx, Inc. to produce Tolerx's humanized anti-GITR antibody known as TRX518, which is currently in development for cancer and chronic viral indications. Details of the ag…   Read More »
October 20, 2008
Pfizer and UCB have formed a new technology company, Cyclofluidic, established with the goal of accelerating the drug discovery process by allowing researchers to test a broader range of potential new drug in less time. The UK Government&rs…   Read More »
October 20, 2008
Novartis AG is restructuring the management of three of four business units, with plans to cut 550 marketing jobs in an effort to save $80 million annually starting in 2010, according to Joerg Reinhardt, head of the vaccines unit and chief opera…   Read More »
October 17, 2008
Catalent Pharma Solutions received notice that the FDA has approved the sale of a prescription product manufactured at its recently opened pre-filled syringe facility in Brussels, Belgium. Syringes from the Brussels facility will likely be dispensed…   Read More »
October 16, 2008
Charles River Laboratories International opened its 60,000-sq.-ft. preclinical facility in Shanghai. The new facility is aimed at fostering growth in that emerging market by assisting global and local biopharmaceutical companies with their drug devel…   Read More »
October 15, 2008
Catalent Pharma Solutions has opened a new temperature controlled warehouse in Bolton, UK to meet increased demand for clinical supply services, particularly cold-chain storage and distribution. “The opening of the warehouse further enhances Ca…   Read More »
October 15, 2008
Tegrant Corp. created a new joint venture to market its ThermoSafe products in the Asia Pacific region. ThermoSafe Brands Asia will operate as a JV between Tegrant and FEC Corp., a Hong Kong-based investment company focused on the Asian packaging mar…   Read More »
October 14, 2008
Akorn, Inc. has entered into a five-year supply agreement with an undisclosed ophthalmic company. Under the terms of the agreement, Akorn will be responsible for the manufacturing and supply of the ophthalmic product, for which it holds the ANDA. Rev…   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On